Skip to content

Exploration of a Precise Diagnosis and Minimally Invasive Treatment System for Early-Stage Lung Cancer Guided by Electromagnetic Navigation Bronchoscopy (ENB) and Cone-Beam CT (CBCT)

Exploration of a Precise Diagnosis and Minimally Invasive Treatment System for Early-Stage Lung Cancer Guided by Electromagnetic Navigation Bronchoscopy (ENB) and Cone-Beam CT (CBCT)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500099117
Enrollment
Unknown
Registered
2025-03-18
Start date
2025-03-20
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early stage lung cancer

Interventions

Sponsors

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-85 years old; 2. Chest CT found lung nodules with a diameter of <=3cm, suspected stage IA lung cancer; 3. Nodules are not suitable for surgical resection, mainly including the following situations: (1) the two lesions in the lung = are considered malignant and cannot be completely removed by surgery, and can be treated by hybrid surgery (i.e., the combined application of multiple treatment methods), and ablation is used as one of the treatment methods; (2) Those who cannot tolerate surgery or have poor general condition, such as advanced age, cardiopulmonary insufficiency, or serious underlying diseases; (3) Those who have undergone lung resection in the past, have poor lung function reserve, and are not suitable for reoperation; (4) The location of the lesion is deep, limited by important anatomical structures, and the surgical loss is large or the risk is high; 4. Patient with informed consent and voluntary participation in the study;

Exclusion criteria

Exclusion criteria: 1.Severe cardiopulmonary insufficiency, unable to tolerate ENB examination or general anesthesia. 2.Severe coagulation disorders. 3.Coexisting severe chronic diseases or other malignancies. 4.Poor compliance, unable to adhere to regular follow-ups. 5.Currently participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Diagnosis and Treatment Outcomes;Safety outcome;

Secondary

MeasureTime frame
Radiation dose control;Technical optimization and standardization;Real-time assessment of ablation efficacy;Long-term outcome;Patient-reported outcomes;

Countries

China

Contacts

Public ContactXu Yuan

Peking Union Medical College Hospital

mdzyxy@163.com+86 10 69152632

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026